Loading stock data…
$116.44+0.55 (+0.47%)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products.
Aflac Incorporated in the Financial Services sector is trading at $116.44 with a market capitalization of $58.8B. Wall Street consensus targets $117.13 (15 analysts), implying a +0.6% move over the next 12 months. The stock is currently 11% below its 52-week high of $130.22, remaining 1.8% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.19B↓ | $4.41B↓ | $4.89B↑ | $4.79B↑ | $4.22B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $1.06B↓ | $1.28B↓ | $1.63B↓ | $2.05B↑ | $874.00M |
| Net Income | $825.00M↓ | $1.02B↓ | $1.38B↓ | $1.64B↑ | $599.00M |
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insuran...
Academic risk and quality models computed from AFL's own filings and price history, not from analyst opinion.
Weak: only 3 of 9 fundamental-health tests pass, which is the range associated with deteriorating fundamentals.
Altman Z below 1.81, the financial-distress band. This measures balance-sheet stress, not share-price direction.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
GARCH(1,1) 30-day annualised forecast, below the current 16.8% reading.
Fama-French 5-factor market beta. The five factors explain 22% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-13.